AU
UK
CA
NZ
IND
US
Colgate-Palmolive (NYSE: CL), the manufacturer of toothpaste, experienced a 1.4% increase in its stock value, reaching US$71.9, following a rating upgrade by Stifel from 'hold' to 'buy.' Stifel is optimistic about the company's organic sales growth in FY23.
Broker Needham recently raised its ratings on semiconductor manufacturersApplied Materials (NASDAQ: AMAT) and Lam Research Corp. (NASDAQ: LRCX). Needham upgraded both stocks to ‘buy’ from ‘hold’.
General merchandise retailerTarget Corp. (NYSE: TGT)received a rating upgrade from broker BofA. TGT price rose by around 3% post the rating upgrade from BofA on October 12, 2023.
Biopharmaceutical firmNeumora Therapeutics (NASDAQ: NMRA)received a ‘buy’ rating from brokers shortly after its recent listing on the stock market. The stock debuted on the market last month and its price has declined by 28.5% since then.
Broker BofA increased its price target onEli Lilly and Company (NYSE: LLY), a pharmaceutical firm with its key areas of focus being neuroscience, cancer, and immunology. Eli Lilly’s market cap stood at over US$500 billion on Friday
Brokerage RBC initiated its coverage onJohnson & Johnson (NYSE: JNJ), giving the stock an ‘outperform’ rating. The broker et its price target at US$178, an upside potential of over 13% over Thursday’s closing price.
Broker UBS raised its rating onFlour Corp. (NYSE: FLR), to ‘buy’ from ‘neutral’. UBS elevated its price target on the construction firm by US$12 to US$47, which marks an upside potential of 36% over FLR’s closing price on Wednesday.
DrugmakerStructure Therapeutics (NASDAQ: GPCR) saw its share price rising on October 3, 2023, after broker BMO raised its price target on the company. BMO Capital Markets raised its price target on GPCR from US$40 to US$83, leading the stock price to rise by 1.6% …
REIT firmDigitalBridge (NYSE: DBRG)received a rating upgrade from broker J.P. Morgan before market open on September 28, 2023.
BTIG upgraded its price target on REIT firm Hudson Pacific to US$11, the highest price target among all brokers as per EODHD/Others data. The new price target reflects an upside potential of 63.2% over the stock’s closing price on Tuesday.
Please wait processing your request...